89 related articles for article (PubMed ID: 11283940)
1. Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma.
Okusaka T; Okada S; Tokuuye K; Wakasugi H; Saisho H; Ishikawa O; Matsuno S; Sato T; Sato K;
Cancer; 2001 Apr; 91(7):1384-9. PubMed ID: 11283940
[TBL] [Abstract][Full Text] [Related]
2. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
Thomas CR; Weiden PL; Traverso LW; Thompson T
Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer.
Shinchi H; Maemura K; Mataki Y; Kurahara H; Sakoda M; Ueno S; Hiraki Y; Nakajo M; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):152-8. PubMed ID: 21647560
[TBL] [Abstract][Full Text] [Related]
5. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
Ishii H; Okada S; Tokuuye K; Nose H; Okusaka T; Yoshimori M; Nagahama H; Sumi M; Kagami Y; Ikeda H
Cancer; 1997 Apr; 79(8):1516-20. PubMed ID: 9118032
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
[TBL] [Abstract][Full Text] [Related]
7. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
9. Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: a non-comparative randomized phase II trial.
Ducreux M; Giovannini M; Baey C; Llacer C; Bennouna J; Adenis A; Peiffert D; Mornex F; Abbas M; Boige V; Pignon JP; Conroy T; Cellier P; Juzyna B; Viret F
Dig Liver Dis; 2014 Oct; 46(10):950-5. PubMed ID: 25027552
[TBL] [Abstract][Full Text] [Related]
10. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin.
Azria D; Ychou M; Jacot W; Thezenas S; Lemanski C; Senesse P; Prost P; Delard R; Masson B; Dubois JB
Pancreas; 2002 Nov; 25(4):360-5. PubMed ID: 12409830
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy combined with intraoperative radiotherapy for locally advanced pancreatic cancer: a feasibility study.
Kokubo M; Nishimura Y; Shibamoto Y; Sasai K; Hosotani R; Imamura M; Hiraoka M
Oncol Rep; 2000; 7(4):773-6. PubMed ID: 10854542
[TBL] [Abstract][Full Text] [Related]
12. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer.
Shinchi H; Takao S; Noma H; Matsuo Y; Mataki Y; Mori S; Aikou T
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):146-50. PubMed ID: 12007953
[TBL] [Abstract][Full Text] [Related]
13. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas.
Kawakami H; Uno T; Isobe K; Ueno N; Aruga T; Sudo K; Yamaguchi T; Saisho H; Kawata T; Ito H
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1357-62. PubMed ID: 16029793
[TBL] [Abstract][Full Text] [Related]
14. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.
Hurmuzlu M; Monge OR; Smaaland R; Viste A
Dis Esophagus; 2010 Apr; 23(3):244-52. PubMed ID: 19664075
[TBL] [Abstract][Full Text] [Related]
15. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L
Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161
[TBL] [Abstract][Full Text] [Related]
16. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.
André T; Balosso J; Louvet C; Hannoun L; Houry S; Huguier M; Colonna M; Lotz JP; De Gramont A; Bellaïche A; Parc R; Touboul E; Izrael V
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):903-11. PubMed ID: 10705012
[TBL] [Abstract][Full Text] [Related]
17. Survival after combined modality therapy for pancreatic cancer.
Bruckner HW; Kalnicki S; Dalton J; Snady H; Schwartz GK; Chesser MR; Lehrer D; Mandeli J; Harpaz N; Janus C
J Clin Gastroenterol; 1993 Apr; 16(3):199-203. PubMed ID: 8505490
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
19. Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas.
Zimmermann FB; Jeremic B; Lersch C; Geinitz H; Hennig M; Molls M
Hepatogastroenterology; 2005; 52(61):246-50. PubMed ID: 15783041
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil.
Sai H; Mitsumori M; Yamauchi C; Araki N; Okumura S; Nagata Y; Nishimura Y; Hiraoka M
Int J Clin Oncol; 2004 Jun; 9(3):149-53. PubMed ID: 15221597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
